265 related articles for article (PubMed ID: 22327924)
1. Tracking target position variability using intraprostatic fiducial markers and electronic portal imaging in prostate cancer radiotherapy.
Munoz F; Fiandra C; Franco P; Guarneri A; Ciammella P; De Stefanis P; Rondi N; Moretto F; Badellino S; Iftode C; Ragona R; Ricardi U
Radiol Med; 2012 Sep; 117(6):1057-70. PubMed ID: 22327924
[TBL] [Abstract][Full Text] [Related]
2. Portal imaging protocol for radical dose-escalated radiotherapy treatment of prostate cancer.
Mubata CD; Bidmead AM; Ellingham LM; Thompson V; Dearnaley DP
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):221-31. PubMed ID: 9422580
[TBL] [Abstract][Full Text] [Related]
3. Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy.
Graf R; Wust P; Budach V; Boehmer D
Radiat Oncol; 2009 Apr; 4():13. PubMed ID: 19397824
[TBL] [Abstract][Full Text] [Related]
4. Daily CT localization for correcting portal errors in the treatment of prostate cancer.
Lattanzi J; McNeely S; Hanlon A; Das I; Schultheiss TE; Hanks GE
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1079-86. PubMed ID: 9719118
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of margins in pelvic lymph nodes and prostate radiotherapy and the impact of bladder and rectum on prostate position.
Marnouche EA; Hadadi K; Abdelhak M; Benlemlih M; Hommadi M; Zaghba N; Andaloussi Saghir K; Elmarjany M; Sifat H; Mansouri H
Cancer Radiother; 2021 Apr; 25(2):161-168. PubMed ID: 33454191
[TBL] [Abstract][Full Text] [Related]
6. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma.
Chung PW; Haycocks T; Brown T; Cambridge Z; Kelly V; Alasti H; Jaffray DA; Catton CN
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):329-34. PubMed ID: 15337572
[TBL] [Abstract][Full Text] [Related]
7. Daily online localization using implanted fiducial markers and its impact on planning target volume for carcinoma prostate.
Khosa R; Nangia S; Chufal KS; Ghosh D; Kaul R; Sharma L
J Cancer Res Ther; 2010; 6(2):172-8. PubMed ID: 20622364
[TBL] [Abstract][Full Text] [Related]
8. Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.
Böckelmann F; Putz F; Kallis K; Lettmaier S; Fietkau R; Bert C
Strahlenther Onkol; 2020 Jul; 196(7):647-656. PubMed ID: 32157345
[TBL] [Abstract][Full Text] [Related]
9. Impact of inter- and intrafraction deviations and residual set-up errors on PTV margins. Different alignment techniques in 3D conformal prostate cancer radiotherapy.
Langsenlehner T; Döller C; Winkler P; Gallé G; Kapp KS
Strahlenther Onkol; 2013 Apr; 189(4):321-8. PubMed ID: 23443612
[TBL] [Abstract][Full Text] [Related]
10. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging.
Schallenkamp JM; Herman MG; Kruse JJ; Pisansky TM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):800-11. PubMed ID: 16199313
[TBL] [Abstract][Full Text] [Related]
11. First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate.
Deutschmann H; Kametriser G; Steininger P; Scherer P; Schöller H; Gaisberger C; Mooslechner M; Mitterlechner B; Weichenberger H; Fastner G; Wurstbauer K; Jeschke S; Forstner R; Sedlmayer F
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1624-32. PubMed ID: 22209149
[TBL] [Abstract][Full Text] [Related]
12. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
[TBL] [Abstract][Full Text] [Related]
13. Positioning accuracy and daily dose assessment for prostate cancer treatment using in-room CT image guidance at a proton therapy facility.
Maeda Y; Sato Y; Minami H; Yasukawa Y; Yamamoto K; Tamamura H; Shibata S; Bou S; Sasaki M; Tameshige Y; Kume K; Ooto H; Kasahara S; Shimizu Y; Saga Y; Omoya A; Saitou M
Med Phys; 2018 May; 45(5):1832-1843. PubMed ID: 29532489
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of daily online set-up errors and organ displacement uncertainty during conformal radiation treatment of the prostate.
Osei EK; Jiang R; Barnett R; Fleming K; Panjwani D
Br J Radiol; 2009 Jan; 82(973):49-61. PubMed ID: 18955413
[TBL] [Abstract][Full Text] [Related]
15. Application of the No Action Level (NAL) protocol to correct for prostate motion based on electronic portal imaging of implanted markers.
de Boer HC; van Os MJ; Jansen PP; Heijmen BJ
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):969-83. PubMed ID: 15752876
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration.
Parker CC; Damyanovich A; Haycocks T; Haider M; Bayley A; Catton CN
Radiother Oncol; 2003 Feb; 66(2):217-24. PubMed ID: 12648794
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon.
Jones BL; Gan G; Diot Q; Kavanagh B; Timmerman RD; Miften M
Med Phys; 2012 Jun; 39(6):3080-8. PubMed ID: 22755693
[TBL] [Abstract][Full Text] [Related]
18. Appropriate patient instructions can reduce prostate motion.
Graf R; Boehmer D; Nadobny J; Budach V; Wust P
Radiat Oncol; 2012 Aug; 7():125. PubMed ID: 22852559
[TBL] [Abstract][Full Text] [Related]
19. Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion.
Shimizu S; Osaka Y; Shinohara N; Sazawa A; Nishioka K; Suzuki R; Onimaru R; Shirato H
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e393-9. PubMed ID: 21658857
[TBL] [Abstract][Full Text] [Related]
20. Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy.
Schiffner DC; Gottschalk AR; Lometti M; Aubin M; Pouliot J; Speight J; Hsu IC; Shinohara K; Roach M
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):610-9. PubMed ID: 17236978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
